Transseptal Mitral ViV with SAPIEN 3 Valve Shows Good Results at 1 Year
A recent analysis of the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy (STS/ACC TVT) Registry shows that transcatheter mitral valve-in-valve (MViV) with the transseptal SAPIEN 3 valve (Edwards Lifesciences) was associated with rare procedural complications and low mortality.